UPDATE 1-EU health regulator warns some hep C drugs could reactivate hep B

Dec 2 (Reuters) - The European Medicines Agency warned on Friday that some of the most successful hepatitis C treatments on the market could reactivate hepatitis B in patients, the second time this year it has raised safety concerns over these treatments.